This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kelley, D. E. Articles by Thaete, F. L. Search for Related Content PubMed PubMed Citation Articles by Kelley, D. E. Articles by Thaete, F. L.

Plasma Fatty Acids, Adiposity, and Variance of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus

Departments of Medicine (D.E.K., K.V.W., T.M.M., B.H.G.) and Radiology (J.C.P., F.L.T.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261; and Medical Research Service, Pittsburgh Veterans Affairs Medical Center (D.E.K.), Pittsburgh, Pennsylvania 15240

Address all correspondence and requests for reprints to: David E. Kelley, M.D., Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, 3459 Fifth Avenue, MUH N809, Pittsburgh, Pennsylvania 15213.

Abstract

Skeletal muscle insulin resistance (IR) is typically severe in type 2 diabetes mellitus (DM). However, the factors that account for interindividual differences in the severity of IR are not well understood. The current study was undertaken to examine the respective roles of plasma FFA, regional adiposity, and other metabolic factors as determinants of the severity of skeletal muscle IR in type 2 DM. Twenty-three subjects (12 women and 11 men) with type 2 DM underwent positron emission tomography imaging using [¹⁸F]2-fluoro-2-deoxyglucose during euglycemic insulin infusions (120 mU/min·m²) to measure skeletal muscle IR, using Patlak analysis of the tissue activity curves. Body composition analysis included body mass index, fat mass, and fat-free mass by dual energy x-ray tomography, and computed tomography determinations of visceral adiposity, thigh adipose tissue distribution, and muscle composition. Body mass index, fat mass, subfascial adiposity in the thigh, and visceral adipose tissue (VAT) were all significantly related to skeletal muscle IR (r = -0.48 to -0.63; P < 0.01). However, the strongest simple correlate of IR in skeletal muscle was insulin-suppressed plasma FFA (r = -0.81; P < 0.001). VAT was the sole component of adiposity that significantly correlated with insulin-suppressed plasma FFA concentration (r = 0.64; P < 0.001). These findings indicate that the severity of skeletal muscle IR in type 2 DM is closely related to the IR of suppressing lipolysis and that plasma fatty acids and VAT are key elements mediating the link between obesity and skeletal muscle IR in type 2 DM.

This article has been cited by other articles:

				M. C. Riddell, V. K. Jamnik, K. E. Iscoe, B. W. Timmons, and N. Gledhill Fat oxidation rate and the exercise intensity that elicits maximal fat oxidation decreases with pubertal status in young male subjects J Appl Physiol, August 1, 2008; 105(2): 742 - 748. [Abstract] [Full Text] [PDF]

				J. E. Galgani, L. K. Heilbronn, K. Azuma, D. E. Kelley, J. B. Albu, X. Pi-Sunyer, S. R. Smith, E. Ravussin, and and the Look AHEAD Adipose Research Group Metabolic Flexibility in Response to Glucose Is Not Impaired in People With Type 2 Diabetes After Controlling for Glucose Disposal Rate Diabetes, April 1, 2008; 57(4): 841 - 845. [Abstract] [Full Text] [PDF]

				K. Azuma, L. K. Heilbronn, J. B. Albu, S. R. Smith, E. Ravussin, D. E. Kelley, and and the Look AHEAD Adipose Research Group Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E435 - E442. [Abstract] [Full Text] [PDF]

				B. Ukropcova, O. Sereda, L. de Jonge, I. Bogacka, T. Nguyen, H. Xie, G. A. Bray, and S. R. Smith Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal Muscle Diabetes, March 1, 2007; 56(3): 720 - 727. [Abstract] [Full Text] [PDF]

				M. A. Tarnopolsky, C. D. Rennie, H. A. Robertshaw, S. N. Fedak-Tarnopolsky, M. C. Devries, and M. J. Hamadeh Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1271 - R1278. [Abstract] [Full Text] [PDF]

				S. R. Smith and P. W. F. Wilson Free Fatty acids and atherosclerosis--guilty or innocent? J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2506 - 2508. [Full Text] [PDF]

				C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E289 - E298. [Abstract] [Full Text] [PDF]

				B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR{gamma} agonists Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E151 - E159. [Abstract] [Full Text] [PDF]

				Y. Tamura, Y. Tanaka, F. Sato, J. B. Choi, H. Watada, M. Niwa, J. Kinoshita, A. Ooka, N. Kumashiro, Y. Igarashi, et al. Effects of Diet and Exercise on Muscle and Liver Intracellular Lipid Contents and Insulin Sensitivity in Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3191 - 3196. [Abstract] [Full Text] [PDF]

				Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF]

				A. Bertoldo, J. Price, C. Mathis, S. Mason, D. Holt, C. Kelley, C. Cobelli, and D. E. Kelley Quantitative Assessment of Glucose Transport in Human Skeletal Muscle: Dynamic Positron Emission Tomography Imaging of [O-Methyl-11C]3-O-Methyl-D-Glucose J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1752 - 1759. [Abstract] [Full Text] [PDF]

				A. M. Poynten, S. K. Gan, A. D. Kriketos, L. V. Campbell, and D. J. Chisholm Circulating Fatty Acids, Non-High Density Lipoprotein Cholesterol, and Insulin-Infused Fat Oxidation Acutely Influence Whole Body Insulin Sensitivity in Nondiabetic Men J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1035 - 1040. [Abstract] [Full Text] [PDF]

				S. D. Driscoll, G. E. Meininger, K. Ljungquist, C. Hadigan, M. Torriani, A. Klibanski, W. R. Frontera, and S. Grinspoon Differential Effects of Metformin and Exercise on Muscle Adiposity and Metabolic Indices in Human Immunodeficiency Virus-Infected Patients J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2171 - 2178. [Abstract] [Full Text] [PDF]

				D. E. Kelley, L. H. Kuller, T. M. McKolanis, P. Harper, J. Mancino, and S. Kalhan Effects of Moderate Weight Loss and Orlistat on Insulin Resistance, Regional Adiposity, and Fatty Acids in Type 2 Diabetes Diabetes Care, January 1, 2004; 27(1): 33 - 40. [Abstract] [Full Text] [PDF]

				D. E. Kelley, T. M. McKolanis, R. A. F. Hegazi, L. H. Kuller, and S. C. Kalhan Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E906 - E916. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Fat Metabolism and Diabetes: 2003 American Diabetes Association Postgraduate Course Diabetes Care, July 1, 2003; 26(7): 2198 - 2203. [Full Text] [PDF]

				K. V. Williams, A. Bertoldo, P. Kinahan, C. Cobelli, and D. E. Kelley Weight Loss-Induced Plasticity of Glucose Transport and Phosphorylation in the Insulin Resistance of Obesity and Type 2 Diabetes Diabetes, July 1, 2003; 52(7): 1619 - 1626. [Abstract] [Full Text] [PDF]

				D. Kim, S. Nam, C. Ahn, K. Kim, S. Yoon, J. Kim, B. Cha, S. Lim, K. Kim, H. Lee, et al. Correlation Between Midthigh Low- Density Muscle and Insulin Resistance in Obese Nondiabetic Patients in Korea Diabetes Care, June 1, 2003; 26(6): 1825 - 1830. [Abstract] [Full Text] [PDF]

				A. D. Kriketos, S. M. Furler, S. K. Gan, A. M. Poynten, D. J. Chisholm, and L. V. Campbell Multiple Indexes of Lipid Availability Are Independently Related to Whole Body Insulin Action in Healthy Humans J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 793 - 798. [Abstract] [Full Text] [PDF]